193 related articles for article (PubMed ID: 20175999)
1. Effect of angiotensin II on the WNK-OSR1/SPAK-NCC phosphorylation cascade in cultured mpkDCT cells and in vivo mouse kidney.
Talati G; Ohta A; Rai T; Sohara E; Naito S; Vandewalle A; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2010 Mar; 393(4):844-8. PubMed ID: 20175999
[TBL] [Abstract][Full Text] [Related]
2. WNK-OSR1/SPAK-NCC signal cascade has circadian rhythm dependent on aldosterone.
Susa K; Sohara E; Isobe K; Chiga M; Rai T; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2012 Nov; 427(4):743-7. PubMed ID: 23044422
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
[TBL] [Abstract][Full Text] [Related]
4. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
5. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.
Chiga M; Rafiqi FH; Alessi DR; Sohara E; Ohta A; Rai T; Sasaki S; Uchida S
J Cell Sci; 2011 May; 124(Pt 9):1391-5. PubMed ID: 21486947
[TBL] [Abstract][Full Text] [Related]
6. Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.
Susa K; Kita S; Iwamoto T; Yang SS; Lin SH; Ohta A; Sohara E; Rai T; Sasaki S; Alessi DR; Uchida S
Clin Exp Nephrol; 2012 Aug; 16(4):530-8. PubMed ID: 22294159
[TBL] [Abstract][Full Text] [Related]
7. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
8. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
9. Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney.
Sohara E; Rai T; Yang SS; Ohta A; Naito S; Chiga M; Nomura N; Lin SH; Vandewalle A; Ohta E; Sasaki S; Uchida S
PLoS One; 2011; 6(8):e24277. PubMed ID: 21909387
[TBL] [Abstract][Full Text] [Related]
10. Modulation of NCC activity by low and high K(+) intake: insights into the signaling pathways involved.
Castañeda-Bueno M; Cervantes-Perez LG; Rojas-Vega L; Arroyo-Garza I; Vázquez N; Moreno E; Gamba G
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1507-19. PubMed ID: 24761002
[TBL] [Abstract][Full Text] [Related]
11. Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.
Mercier-Zuber A; O'Shaughnessy KM
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):534-40. PubMed ID: 21610494
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Na-Cl cotransporter by OSR1 and SPAK kinases regulates its ubiquitination.
Hossain Khan MZ; Sohara E; Ohta A; Chiga M; Inoue Y; Isobe K; Wakabayashi M; Oi K; Rai T; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2012 Aug; 425(2):456-61. PubMed ID: 22846565
[TBL] [Abstract][Full Text] [Related]
13. Exploring the intricate regulatory network controlling the thiazide-sensitive NaCl cotransporter (NCC).
Dimke H
Pflugers Arch; 2011 Dec; 462(6):767-77. PubMed ID: 21927811
[TBL] [Abstract][Full Text] [Related]
14. WNK4 is the major WNK positively regulating NCC in the mouse kidney.
Takahashi D; Mori T; Nomura N; Khan MZ; Araki Y; Zeniya M; Sohara E; Rai T; Sasaki S; Uchida S
Biosci Rep; 2014 May; 34(3):. PubMed ID: 24655003
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.
Ohta A; Rai T; Yui N; Chiga M; Yang SS; Lin SH; Sohara E; Sasaki S; Uchida S
Hum Mol Genet; 2009 Oct; 18(20):3978-86. PubMed ID: 19633012
[TBL] [Abstract][Full Text] [Related]
16. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.
Grimm PR; Taneja TK; Liu J; Coleman R; Chen YY; Delpire E; Wade JB; Welling PA
J Biol Chem; 2012 Nov; 287(45):37673-90. PubMed ID: 22977235
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the WNK4-SPAK/OSR1 pathway has a minor effect on baseline NKCC2 phosphorylation.
Maeoka Y; Nguyen LT; Sharma A; Cornelius RJ; Su XT; Gutierrez MR; Carbajal-Contreras H; Castañeda-Bueno M; Gamba G; McCormick JA
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F39-F56. PubMed ID: 37881876
[TBL] [Abstract][Full Text] [Related]
18. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone.
Chiga M; Rai T; Yang SS; Ohta A; Takizawa T; Sasaki S; Uchida S
Kidney Int; 2008 Dec; 74(11):1403-9. PubMed ID: 18800028
[TBL] [Abstract][Full Text] [Related]
19. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
[TBL] [Abstract][Full Text] [Related]
20. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
